COV2008
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
This study is investigating the safety and efficacy of the Johnson & Johnson Adv.26 booster vaccine in healthy adults who have previously received the Pfizer COVID-19 vaccine. This study is currently enrolling participants.
This study is comparing the immunogenicity and safety of an investigational yellow fever vaccine with the previously approved YF-VAX vaccine. The main purpose of the study is to determine if the study vaccine is safe and creates comparable immune responses to that of the YF-VAX vaccine. This study is currently enrolling.
This study is collecting blood samples and clinical data for storage in a repository from individuals who have received/plan to receive a vaccine against SARS-CoV-2. This study is currently enrolling participants.
This study is assessing antibodies for the prevention of SARS CoV-2 infection of asymptomatic healthy adults.
This study is assessing two different dosages of an investigational COVID-19 vaccine in healthy adults. This trial completed enrollment in August 2020 and is ongoing.
This study is evaluating different vaccine regimens using experimental HIV vaccines in healthy HIV-negative adults. The study finished enrollment in September 2017 and is ongoing.
This study assessed two different dosages of an investigational Zika Virus vaccine in healthy adults. The study closed enrollment in September 2018. Data analysis is underway.
This study assessed different vaccine schedules using two experimental HIV vaccines in healthy HIV-negative adults. The study started in March 2016 and was completed in January 2019.
This study evaluated different vaccine schedules using an investigational Zika Virus vaccine in healthy adults. The study started in October 2016 and was completed in June 2018.
This study assessed different dosages of a monoclonal antibody in healthy HIV-negative and healthy HIV-positive adults. The study closed enrollment in October 2018.
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu